Ambu in brief
Ambu is a Danish multinational medical technology company that develops, produces and delivers innovative healthcare solutions across the fields of single-use endoscopy, anaesthesia and patient monitoring.
We are the market leader within single-use endoscopy, present in the four largest endoscopy segments, pulmonology, ear-nose-throat (ENT), urology and gastroenterology (GI).
Dedicated to partnering with healthcare professionals to provide safe, efficient and high-performing solutions that better the lives of patients, we sells medical devices to hospitals, clinics and emergency services all over the world - supporting millions of healthcare professionals and patients every year.
Ambu is listed on NASDAQ OMX Copenhagen.
Number of employees
Ambu employs approximately 4,600 people across North America, Latin America, Europe and Asia-Pacific.
Business areas
We have two business areas: Endoscopy Solutions and Anaesthesia & Patient Monitoring.
Endoscopy Solutions:
Our portfolio features a range of high-performance single-use flexible endoscopes, as well as our endoscopy systems, the Ambu® aView™ 2 Advance and the Ambu® aBox™ 2.
Anaesthesia & Patient Monitoring:
Our Anaesthesia & Patient Monitoring portfolio includes laryngeal masks, resuscitators, face masks and breathing circuits, as well as cardiology and neurology electrodes.
Production companies
Xiamen, China
Penang, Malaysia
Noblesville, USA
Juárez, Mexico
Key figures
Organic revenue growth: 7.6%
EBIT margin (before special items): 6.3%
Revenue: DKK 4,775 million
Free cash flow: DKK 192m
EBIT (before special items): DKK 302m
Gross margin: 56.8%
(Financial year: 2022/23)
85+ years of innovation
Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions.
We are the market leader in single-use endoscopy, a market we created in 2009 with the world’s first single-use bronchoscope, the Ambu® aScope™. Today, we have expanded our presence across the four major endoscopy segments – pulmonology, ENT (ear-nose-throat), urology and, most recently, GI (gastroenterology).
We pave the way for smarter, simpler and more sustainable ways of working in healthcare.
Our DNA of innovation is tightly linked to our strong heritage of developing innovations that make a true difference in healthcare. In 1956, we invented the world’s first self-inflating resuscitator, the Ambu® Bag™, which is still in use today. It was a major milestone in emergency medical equipment and continues to be a permanent part of hospitals’ and emergency services’ product ranges world-wide.
Our commitment to our customers is unwavering. We deliver innovations that make a real difference to healthcare professionals and their patients by collaborating with leading medical experts to uncover their needs in depth. We listen, and we learn. And we translate those needs into solutions that activate the future.
At our headquarters in Copenhagen, Denmark, and around the world, in Europe, North America, Latin America and the Asia Pacific, 4,600 team members keep Ambu moving forward.
